Skip to main content

In this Issue

  • Mobile app helps patients, cos. increase adherence

    Diabetics are most adherent around meal times, especially during breakfast and toward the beginning of the week, according to a review of Medisafe’s more than 160,000 diabetes patients who utilize its adherence tool in an effort to better manage the condition.

    (To view the full Diabetes Report, click here.)

  • Sundial campaign introduces new ‘Normal’ in hair care

    Shea Moisture is unleashing the second phase of its call-to-action program, #BreakTheWalls.

    This time, the Sundial Brands-owned skin and hair line is challenging the concept of a one-size-fits all representation of beauty.

  • Catering to women’s health needs

    Sam’s Club last month hosted a health screening day specifically catering to the health needs of the women shopping the store with a “Support Her Health” screening offering. “Women often prioritize their families’ needs and work responsibilities over their own health and wellness, but it’s important to ensure regular health checkups don’t fall off the to-do list,” said Tara Raddohl, senior director of corporate communications at Sam’s Club.

  • No switch? No problem. OTC sales strong

    Sales of OTC medicines continued on a strong growth trajectory of more than 3%, growing by approximately $1.4 billion in dollar volume to $45.6 billion for the 52 weeks ended Oct. 2, according to IRI data. And that’s primarily organic growth from existing brands; there were no big Rx-to-OTC switches driving the kind of gangbuster growth as there were in each of the two years prior.

    (To view the full OTC Trend Report, click here.)

  • Specialty Focused: DSN interviews Walgreens specialty pharmacy group VP

    The significant role that specialty pharmacies play in specialty care — from ensuring patients have access to their specific disease state treatment to delivering necessary training and other services around their medication — is something Walgreens Specialty Pharmacy knows well.

  • BI launches new combination antacid

    Boehringer Ingelheim is looking to spark some excitement across the antacids aisle with the June launch of its Duo Fusion combination antacid, “from the makers of Zantac,” which couples a fast-acting heartburn remedy with an H2 blocker to provide both immediate and longer-lasting relief from heartburn. “We saw an opportunity to trade up consumers from antacids to an H2 [blocker],” said Marc Rovner, general manager Boehringer Ingelheim Consumer Healthcare, in an interview with Drug Store News.

  • Private label, Bayer drive down internal analgesics

    Internal analgesics is slightly down in retail sales with a 0.6% decrease year-over-year. As the largest segment in internal analgesics, tablets were down 0.4%. This performance was driven down primarily by private label and Bayer products. Private-label internal analgesics were down 5%, and Bayer was down 4%. Pfizer saw no change in sales. McNeil’s return to the market did well, reflecting a 17% increase over the same time period last year. The external analgesic category was up 7% year-over-year.

  • Harry’s debut at Target attracts majority of customer base

    Not too long after Unilever’s blockbuster deal with Dollar Shave Club was announced, another online razor company made its own news. Harry’s inked a deal to sell through Target, complete with an inline presentation and an endcap decked out with a huge Harry’s signature razor.

    (To view the full Shave Report, click here.)

X
This ad will auto-close in 10 seconds